Maldonado H, Leyton L
Front Cell Dev Biol. 2023; 11:1214787.
PMID: 37519303
PMC: 10382208.
DOI: 10.3389/fcell.2023.1214787.
Obst J, Hall-Roberts H, Smith T, Kreuzer M, Magno L, Di Daniel E
Sci Rep. 2021; 11(1):19842.
PMID: 34615897
PMC: 8494732.
DOI: 10.1038/s41598-021-96144-7.
Jing X, Ren D, Gao F, Chen Y, Wu X, Han Y
Acta Pharm Sin B. 2021; 11(2):394-405.
PMID: 33643819
PMC: 7893143.
DOI: 10.1016/j.apsb.2020.10.024.
Bakthavatsalam D, Craft Jr J, Kazansky A, Nguyen N, Bae G, Caivano A
Front Immunol. 2021; 11:575085.
PMID: 33488575
PMC: 7819857.
DOI: 10.3389/fimmu.2020.575085.
Torres-Gomez A, Cabanas C, Lafuente E
Front Immunol. 2020; 11:738.
PMID: 32425937
PMC: 7203660.
DOI: 10.3389/fimmu.2020.00738.
Hematopoietic or Osteoclast-Specific Deletion of Syk Leads to Increased Bone Mass in Experimental Mice.
Csete D, Simon E, Alatshan A, Aradi P, Dobo-Nagy C, Jakus Z
Front Immunol. 2019; 10:937.
PMID: 31134061
PMC: 6524727.
DOI: 10.3389/fimmu.2019.00937.
Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression.
Lindau A, Hardtner C, Hergeth S, Blanz K, Dufner B, Hoppe N
Basic Res Cardiol. 2016; 111(2):20.
PMID: 26891724
PMC: 4759214.
DOI: 10.1007/s00395-016-0535-8.
Syk-mediated tyrosine phosphorylation of mule promotes TNF-induced JNK activation and cell death.
Lee C, Yang Y, Chen C, Liu J
Oncogene. 2015; 35(15):1988-95.
PMID: 26212014
PMC: 4729668.
DOI: 10.1038/onc.2015.275.
Functional fingerprinting of human mesenchymal stem cells using high-throughput RNAi screening.
Erdmann G, Suchanek M, Horn P, Graf F, Volz C, Horn T
Genome Med. 2015; 7(1):46.
PMID: 26120366
PMC: 4481116.
DOI: 10.1186/s13073-015-0170-2.
Functional roles of Syk in macrophage-mediated inflammatory responses.
Yi Y, Son Y, Ryou C, Sung G, Kim J, Cho J
Mediators Inflamm. 2014; 2014:270302.
PMID: 25045209
PMC: 4090447.
DOI: 10.1155/2014/270302.
Macrophages require Skap2 and Sirpα for integrin-stimulated cytoskeletal rearrangement.
Alenghat F, Baca Q, Rubin N, Pao L, Matozaki T, Lowell C
J Cell Sci. 2012; 125(Pt 22):5535-45.
PMID: 22976304
PMC: 3561861.
DOI: 10.1242/jcs.111260.
Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas.
Hatton O, Lambert S, Krams S, Martinez O
PLoS One. 2012; 7(8):e42610.
PMID: 22880054
PMC: 3411813.
DOI: 10.1371/journal.pone.0042610.
Molecular mechanisms of spontaneous and directed mast cell motility.
Lee J, Veatch S, Baird B, Holowka D
J Leukoc Biol. 2012; 92(5):1029-41.
PMID: 22859829
PMC: 3476239.
DOI: 10.1189/jlb.0212091.
CCR7/CCL19 controls expression of EDG-1 in T cells.
Shannon L, McBurney T, Wells M, Roth M, Calloway P, Bill C
J Biol Chem. 2012; 287(15):11656-64.
PMID: 22334704
PMC: 3320915.
DOI: 10.1074/jbc.M111.310045.
The protein-tyrosine kinase Syk interacts with the C-terminal region of tensin2.
Moon K, Zhang X, Zhou Q, Geahlen R
Biochim Biophys Acta. 2011; 1823(2):199-205.
PMID: 22019427
PMC: 3273629.
DOI: 10.1016/j.bbamcr.2011.10.001.
Expression of the C-C chemokine receptor 7 mediates metastasis of breast cancer to the lymph nodes in mice.
Cunningham H, Shannon L, Calloway P, Fassold B, Dunwiddie I, Vielhauer G
Transl Oncol. 2010; 3(6):354-61.
PMID: 21151474
PMC: 3000460.
DOI: 10.1593/tlo.10178.
The SYK tyrosine kinase: a crucial player in diverse biological functions.
Mocsai A, Ruland J, Tybulewicz V
Nat Rev Immunol. 2010; 10(6):387-402.
PMID: 20467426
PMC: 4782221.
DOI: 10.1038/nri2765.
Genetic deficiency of Syk protects mice from autoantibody-induced arthritis.
Jakus Z, Simon E, Balazs B, Mocsai A
Arthritis Rheum. 2010; 62(7):1899-910.
PMID: 20201079
PMC: 2972644.
DOI: 10.1002/art.27438.
Galectin-1 co-clusters CD43/CD45 on dendritic cells and induces cell activation and migration through Syk and protein kinase C signaling.
Fulcher J, Chang M, Wang S, Almazan T, Hashimi S, Eriksson A
J Biol Chem. 2009; 284(39):26860-70.
PMID: 19635795
PMC: 2785374.
DOI: 10.1074/jbc.M109.037507.
Role of the protein tyrosine kinase Syk in regulating cell-cell adhesion and motility in breast cancer cells.
Zhang X, Shrikhande U, Alicie B, Zhou Q, Geahlen R
Mol Cancer Res. 2009; 7(5):634-44.
PMID: 19435818
PMC: 2788757.
DOI: 10.1158/1541-7786.MCR-08-0371.